Article Text
Statistics from Altmetric.com
QUESTION: In patients with major depression, is St John's wort (Hypericum extract) better than placebo for reducing depressive symptoms?
Design
Randomised (allocation concealed*), blinded {clinicians, patients, outcome assessors, and statisticians}†,* placebo controlled trial with 8 weeks of follow up.
Setting
11 academic medical centres in the USA.
Patients
200 physically healthy outpatients who were ≥ 18 years of age (mean age 42.4 y, 64% women); had major depression (single episode or recurrent) without psychotic features according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition for ≥ 4 weeks; and scored ≥ 20 on the Hamilton Depression Rating Scale (HDRS). Exclusion criteria included having cognitive, post-traumatic stress, eating, or substance use disorders in the previous 6 months; panic disorder in the previous year; and bipolar, psychotic, or primary personality disorders. Patients who improved during the 1 week placebo run-in period were …
Footnotes
-
Sources of funding: Pfizer Inc. and National Institute of Mental Health.
-
For correspondence: Dr R C Shelton, 1500 21st Avenue South, Suite 2200, Nashville, TN 37212, USA. Fax +1 615 343 9038.
-
Abstract and commentary also appear in Evidence-Based Mental Health.
-
↵† Information provided by author.